High-performance liquid chromatographic determination of quercetin in human plasma and urine utilizing solid-phase extraction and ultraviolet detection

Ishii, K.; Furuta, T.; Kasuya, Y.

Journal of Chromatography. B Analytical Technologies in the Biomedical and Life Sciences 794(1): 49-56

2003


ISSN/ISBN: 1570-0232
PMID: 12888197
DOI: 10.1016/s1570-0232(03)00398-2
Accession: 010752826

Download citation:  
Text
  |  
BibTeX
  |  
RIS

Article/Abstract emailed within 0-6 h
Payments are secure & encrypted
Powered by Stripe
Powered by PayPal

Abstract
An HPLC method for determining quercetin in human plasma and urine is presented for application to the pharmacokinetic study of rutin. Isocratic reversed-phase HPLC was employed for the quantitative analysis by using kaempferol as an internal standard. Solid-phase extraction was performed on an OasisTM HLB cartridge (>95% recovery). The HPLC assay was carried out using a Luna ODS-2 column (150X2.1 mm I.D., 5 mum particle size). The mobile phase was acetonitrile-10 mM ammonium acetate solution containing 0.3 mM EDTA-glacial acetic acid, 29:70:1 (v/v, pH 3.9) and 26:73:1 (v/v, pH 3.9) for the determination of plasma and urinary quercetin, respectively. The flow-rate was 0.3 ml/min and the detection wavelength was set at 370 nm. Calibration of the overall analytical procedure gave a linear signal (r>0.999) over a concentration range of 4-700 ng/ml of quercetin in plasma and 20-1000 ng/ml of quercetin in urine. The lower limit of quantification was apprx7 ng/ml of quercetin in plasma and apprx35 ng/ml in urine. The detection limit (defined at a signal-to-noise ratio of about 3) was apprx0.35 ng/ml in plasma and urine. A preliminary experiment to investigate the plasma concentration and urinary excretion of quercetin after oral administration of 200 mg of rutin to a healthy volunteer demonstrated that the present method was suitable for determining quercetin in human plasma and urine.